Drawing a line?—Visuo-constructive function as discriminator between healthy individuals, subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease and predictor of disease progress compared to a multimodal approach
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2194-1327
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Drawing a line?—Visuo-constructive function as discriminator between healthy individuals, subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease and predictor of disease progress compared to a multimodal approach ; day:1 ; month:2 ; year:2023 ; pages:1-11
Neuropsychiatrie ; (1.2.2023), 1-11
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40211-022-00455-8
- URN
-
urn:nbn:de:101:1-2023051122163160460831
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 09:04 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tokaj, Amelie
- Lehrner, Johann
- SpringerLink (Online service)
Ähnliche Objekte (12)
Assessing visuo-constructive functions in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease with the Vienna Visuo-Constructional Test 3.0 (VVT 3.0)
Will cognitive mapping hinder Alzheimer’s Disease?
Diet and Inflammation in Cognitive Ageing and Alzheimer’s Disease
Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
Neural mechanisms of cognitive reserve in Alzheimer's disease
The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease
Cognitive biomarker prioritization in Alzheimer’s Disease using brain morphometric data
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease
PACAP–Sirtuin3 alleviates cognitive impairment through autophagy in Alzheimer’s disease
Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment
Assessing visuo-constructive functions in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease with the Vienna Visuo-Constructional Test 3.0 (VVT 3.0)
Will cognitive mapping hinder Alzheimer’s Disease?
Diet and Inflammation in Cognitive Ageing and Alzheimer’s Disease
Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
Neural mechanisms of cognitive reserve in Alzheimer's disease
The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease
Cognitive biomarker prioritization in Alzheimer’s Disease using brain morphometric data
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease
PACAP–Sirtuin3 alleviates cognitive impairment through autophagy in Alzheimer’s disease
Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment
Assessing visuo-constructive functions in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease with the Vienna Visuo-Constructional Test 3.0 (VVT 3.0)
Will cognitive mapping hinder Alzheimer’s Disease?
Diet and Inflammation in Cognitive Ageing and Alzheimer’s Disease
Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
Neural mechanisms of cognitive reserve in Alzheimer's disease
The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease
Cognitive biomarker prioritization in Alzheimer’s Disease using brain morphometric data
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease
PACAP–Sirtuin3 alleviates cognitive impairment through autophagy in Alzheimer’s disease